Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oumarou Nabi

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Hepatology (Baltimore, Md.)|January 22, 2024
Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLDOumarou Nabi, Nathanaël Lapidus, Jerome Boursier, et al.
Journal of Internal Medicine|February 6, 2026
Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease in Sweden: Insights from the SCAPIS cohortOumarou Nabi, Jonas Spaak, Göran Bergström, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Hepatology (Baltimore, Md.)|January 22, 2024
Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLDOumarou Nabi, Nathanaël Lapidus, Jerome Boursier, et al.
Journal of Internal Medicine|February 6, 2026
Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease in Sweden: Insights from the SCAPIS cohortOumarou Nabi, Jonas Spaak, Göran Bergström, et al.
Pageof 2